NPPA
Health
₹8,447 Crore in Medicine Overcharging Claims Remain Outstanding
India has ₹8,447.4 crore in outstanding medicine overcharging claims, according to figures from the National Pharmaceutical Pricing Authority as of March 31, 2026. The Supreme Court has also questioned whether trade-margin restrictions introduced for anti-cancer medicines should be extended to other medicines and medical products.
Hindi News
कैंसर की दवाओं पर सरकार का बड़ा फैसला, कीमतें 70% तक घटेंगी
कैंसर की गैर-अनुसूचित दवाओं पर ट्रेड मार्जिन 30% तय किया गया है। सरकार के मुताबिक, इससे मरीजों को सालाना 2,500 करोड़ रुपये की बचत हो सकती है।
Health
India Caps Cancer Drug Trade Margins at 30% of MRP
India caps trade margins on non-scheduled cancer drugs at 30% of MRP, aiming to cut prices by up to 70% and save patients ₹2,500 crore annually.